First trimester termination of pregnancy

被引:12
|
作者
Lui, Man-Wa [1 ]
Ho, Pak-Chung [1 ]
机构
[1] Univ Hong Kong, Dept Obstet & Gynaecol, Queen Mary Hosp, 6-F Professorial Block,102 Pokfulam Rd, Hong Kong, Peoples R China
关键词
First trimester; Termination of pregnancy; Vacuum aspiration; Misoprostol; Mifepristone; EARLY MEDICAL ABORTION; RANDOMIZED CONTROLLED-TRIAL; ELECTRIC VACUUM ASPIRATION; CERVICAL-DILATION; SURGICAL ABORTION; MIFEPRISTONE-MISOPROSTOL; 1ST-TRIMESTER ABORTION; PARACERVICAL-BLOCK; INTERVALS; EFFICACY;
D O I
10.1016/j.bpobgyn.2019.06.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
First trimester termination of pregnancy (TOP) is a safe and effective procedure. The complete abortion rates of surgical and medical abortion are approximately 97% and 95%, respectively. Vacuum aspiration (VA) either by electrical suction or manual aspiration is the method of choice for surgical TOP. Risk of significant bleeding is <= 5% in VA, while major complications occur in <1%. The risk of infection after VA can be reduced significantly by using prophylactic antibiotics or by the screen-and-treat strategy. Pre-operative administration of misoprostol can also reduce the risk of complications. The combination of 200 mg mifepristone followed by 800 mu g misoprostol 24-48 h later is recommended for first trimester medical TOP. If mifepristone is not available, misoprostol can also be used alone, but repeated doses may be required and the complete abortion rate may be lower. Due to the reduced efficacy in more advanced gestation, repeated doses of misoprostol may be required for medical TOP over 9 weeks of gestation. The complete abortion rate with this regimen is 95% or more. Gastrointestinal upsets can occur in up to 50% of women, but major complications are rare. There was no lower limit of gestational week for TOP, although extra precaution is required for the confirmation of completion of procedures and exclusion of ectopic pregnancy. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [1] Misoprostol and first trimester pregnancy termination
    Grapsas, X.
    Liberis, V.
    Vassaras, G.
    Tsikouras, P.
    Vlachos, G.
    Galazios, G.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2008, 35 (01): : 32 - 34
  • [2] Medical termination of pregnancy in the early first trimester
    Hamoda, H
    Flett, GMM
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (01): : 10 - 14
  • [3] Sublingual misoprostol for first trimester termination of pregnancy
    Fekih, Myriam
    Fathallah, Khadija
    Ben Regaya, Lassad
    Bouguizane, Sassi
    Chaieb, Anouar
    Bibi, Mohamed
    Khairi, Hedi
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (01) : 67 - 70
  • [4] Vaginal misoprostol for first trimester pregnancy termination
    Mohindra, Vineeta
    Kumar, Sushil V. S. M.
    Antony, Z. K.
    Kumar, Reema
    Shringarpure, Prajakta
    [J]. JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2005, 55 (04): : 358 - 360
  • [5] KARMAN CANNULA AND FIRST-TRIMESTER TERMINATION OF PREGNANCY
    LIU, DTY
    HUDSON, I
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 118 (07) : 906 - 909
  • [6] First trimester medical termination of pregnancy: The Nottingham experience
    Singh, M.
    Porter, C.
    Griffiths, S.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 28 (03) : 315 - 316
  • [7] Preparation of the cervix for surgical termination of pregnancy in the first trimester
    Singh, K
    Fong, YF
    [J]. HUMAN REPRODUCTION UPDATE, 2000, 6 (05) : 442 - 448
  • [8] TERMINATION OF FIRST TRIMESTER PREGNANCY BY EXTRAOVULAR PROSTAGLANDIN-IMPACT
    ZOLTAN, I
    CSILLAG, M
    ZSOLNAI, B
    ZUBEK, L
    MOKSONY, I
    MATANYI, S
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1974, 6 (03) : 211 - 216
  • [9] Sublingual misoprostol for first trimester termination of pregnancy: safety concerns
    Tang, OS
    [J]. HUMAN REPRODUCTION, 2002, 17 (10) : 2778 - 2778
  • [10] Outcome of first trimester medical termination of pregnancy: definitions and management
    Fiala, Christian
    Cameron, Sharon
    Bombas, Teresa
    Parachini, Mirella
    Agostini, Aubert
    Lertxundi, Roberto
    Lubusky, Marek
    Saya, Laurence
    Danielsson, Kristina Gemzell
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2018, 23 (06): : 451 - 457